RPRX
$68.68+0.23%
as of close, Nov 17, 2026
☾ AH $68.68 +0.23%
Royalty Pharma plcStock · HealthcareNasdaq Composite · 0.05% of ONEQRussell 1000 · 0.03% of IWBRussell 3000 · 0.03% of IWVMSCI World · 0.03% of URTHMSCI ACWI · 0.02% of ACWI
Head-to-head:Compare with INCY or any ticker →
Royalty Pharma plc total returns by year (including dividends)
As of market close, Nov 17, 2026
Every year since 2020#
Data provided bySource: Twelve DataCalendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start | End | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $38.64 | $68.68 | 3.1% | +80.8% | |
| 2025 | $25.51 | $38.64 | 3.8% | +55.3% | |
| 2024 | $28.09 | $25.51 | 2.8% | -6.4% | |
| 2023 | $39.52 | $28.09 | 1.8% | -27.1% | |
| 2022 | $39.85 | $39.52 | 1.8% | +1.0% | |
| 2021 | $50.05 | $39.85 | 1.3% | -19.1% | |
| 2020since Jun 16 | $44.50 | $50.05 | 0.9% | +13.3% |
- Annualized
- +7.9%
- 2021–2026
- Average year
- +0.7%
- 5 full years
- Best year
- +55.3%
- 2025
- Worst year
- -27.1%
- 2023
- Positive years
- 2/5
- 40% up
Annualized (CAGR)
+7.9%
2021–2026
Average year
+0.7%
5 full years
Best year
+55.3%
2025
Worst year
-27.1%
2023
Positive years
2/5
40% up
Total return by period#
Annual
−100%−50%0%50%100%
2020, since Jun 16+13%'20
2021-19%'21
2022+0.99%'22
2023-27%'23
2024-6.4%'24
2025+55%'25
2026+81%'26
Methodology#
Total returns, dividends reinvested, measured on RPRX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Royalty Pharma plc's average annual return?
- Since 2021, Royalty Pharma plc (RPRX) has returned about 7.9% a year (the compound annual growth rate) and an average calendar-year return of 0.7%.
- What were Royalty Pharma plc's best and worst years?
- Over 2021–2026, the best year was 2025 (+55.3%) and the worst was 2023 (-27.1%).
- How often is Royalty Pharma plc up in a year?
- 2 of the 5 full years since 2021 were positive — about 40% of the time.
More on Royalty Pharma plc
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with INCY or any ticker →
